Malignant Melanoma Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01962103Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsTreatment